Stock PHAR PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up

All News Pharming Group N.V. Nasdaq

Equities

PHAR

US71716E1055

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
7.68 USD -12.23% Intraday chart for Pharming Group N.V. -17.24% -32.81%
May. 31 Pharming Group Flags Delay in EU Review of Rare Immunodeficiency Drug MT
May. 30 Pharming Group N.V. Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of Apds in the European Union CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pharming N : Jefferies Healthcare Conference Presentation June 5 6, 2024
PU
Pharming Group to participate in June investor conferences
GL
Pharming Group Flags Delay in EU Review of Rare Immunodeficiency Drug
MT
Pharming N : Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union - Form 6-K
PU
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
GL
Pharming Group N.V. Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of Apds in the European Union
CI
Pharming N : Physical Settlement Notice 2029 Convertible Bonds
PU
Pharming N : Publication of Voting Results of the AGM 2024
PU
Pharming N : Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
PU
Pharming N : Presentation AGM 2024
PU
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
GL
Transcript : Pharming Group N.V. - Shareholder/Analyst Call
Pharming Group to participate in May investor conference
GL
Pharming N : Presentatie - mei 2024
PU
Pharming N : Corporate Presentation - May 2024
PU
Pharming N : 1Q 2024 financial results - Analyst & Investor Call transcript
PU
Pharming N : Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
PU
Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
GL
Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024
Pharming N : 1Q 2024 Financial Results Presentation - May 8, 2024
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. PHAR Stock
  5. News Pharming Group N.V.